Skip to content

DR. STEFAAN BAFORT

Active Private limited companyfounded 1996active for 29 yearsSteensedijk 396, 8400 OstendKBO/BCE: BE 0459.642.022 #10 company by equity in Ostend, Health and social work sector

Lifetime

19 annual accounts with figures on one time axis, 28 filings since 1998
peak of €826,381 in 2022
€584,405▲ 38.3%
lowest -€292,106 in 2013
€210,530▼ 17.4%
peak of €3.3m in 2025
€3.3m▲ 6.7%
€41,801▼ 37.5%
peak of 0.9 FTE in 2020
0.3 FTEunchanged
Board2 names since 2015
2 directors and 1 other
Documentsfilings and deeds
30-01-20261 day before the deadline
2025abbreviated format
Gross margin from €422,545 to €584,405Debts from €66,862 to €41,801Investments €274,725Cash from €113,340 to €76,542

Key points

from the 2025 annual accounts

Equity

€3.3m ▲ 6.7%

DR. STEFAAN BAFORT has made a profit without a break since 2020.

Turnover

≈ €880,000 estimated

The accounts state no turnover.

Investments

€274,725 2.1 times depreciation
2022202320242025

Green is investment, beige is depreciation. Land and buildings stand 15.3% higher than in 2024.

Liquidity

62.29 was 39.48 in 2024

Short-term debts fell from €55,111 to €35,062.

Filings

28 annual accounts since 1998
deadline200020102020

The 2017 accounts came 6 days late. The other nine of the last ten were filed on time.

Position in the sector

98.8%

Higher solvency than 95% of companies in human health. The sector median is 59.4%, over 2,821 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,389 companies had the same profile as DR. STEFAAN BAFORT has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,389 companies, not a prediction for DR. STEFAAN BAFORT. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director,
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0459642022
2 managers resigning, 2 directors reappointed (manager) and (manager) resign · (director) and (director) reappointed · acts as permanent representative · Gazette deed
appointed as manager acts as permanent representative · General meeting of 20-06-2015 · Gazette deed
Incorporation published on 08-01-1997 · Gazette deed
All 42 events

Comparable companies

same main activity, similar in size and age
Company
DR. STEFAAN BAFORT Ostend €3.4m €584,405 98.8% 0.3
Dokter Michel Snoecx Roeselare €3.7m €649,790 55.4% 0.5
Dr. Evert Matthys MKA Ypres €4.1m €638,158 98.5% 0.4
Blanckaert MD Ypres €2.7m €634,594 85.7% 0
DOCTEUR BERNARD KITTEL Eupen €3.1m €629,581 87.6% 0.5
ETIMAR MEDICALE Fleurus €2.4m €611,604 99.7% 0.2
DOKTERS DEWANDRE-NYSEN Hasselt €2.7m €655,816 94.3% 0

These companies have the same main activity as DR. STEFAAN BAFORT: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €2.4m and €4.1m, founded between 1990 and 2000.

Official details

Source: KBO
Status
Active since 27-12-1996Normal situation
Activity
Specialist medical practiceNACE 86220and 2 others
Joint committee
330Health institutions and services · annual accounts 30-06-2025
Establishment unit
2.230.134.8198400 Ostend, since 16-12-1996
Financial year end
30 June
Peppol
Reachable since 30-12-2025
Company details

Annual accounts to 30-06-2025

€3.4m▲ 4.8%
Employeeson 30-06-2025
1=
Filing
Filed on 30-01-2026, 1 day before the end of the filing period
Financials

Insights on DR. STEFAAN BAFORT

DR. STEFAAN BAFORT files the abbreviated format. That format states no turnover. The gross margin rose from €300,007 in 2007 to €584,405 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR. STEFAAN BAFORT

What is the company number of DR. STEFAAN BAFORT?
The company number of DR. STEFAAN BAFORT is 0459.642.022. The VAT number is the same number with BE in front: BE 0459.642.022.
Where is DR. STEFAAN BAFORT based?
The registered office is at Steensedijk 396, 8400 Ostend.Company details
What does DR. STEFAAN BAFORT do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. STEFAAN BAFORT?
DR. STEFAAN BAFORT is a private limited company (BV).
When was DR. STEFAAN BAFORT founded?
DR. STEFAAN BAFORT was founded on 27-12-1996.
Is DR. STEFAAN BAFORT still active?
Yes, DR. STEFAAN BAFORT is an active enterprise in the KBO register.
How many employees does DR. STEFAAN BAFORT have?
DR. STEFAAN BAFORT had an average of 0.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does DR. STEFAAN BAFORT fall under?
In its 30-06-2025 annual accounts, DR. STEFAAN BAFORT states joint committee 330 (Health institutions and services).
What is the turnover of DR. STEFAAN BAFORT?
The turnover in financial year 2025 is about €880,000. This figure is estimated from the gross margin of €584,405 and 31 comparable companies (NACE 86220). It probably lies between €780,000 and €1.2m.
Is DR. STEFAAN BAFORT profitable?
In financial year 2025, DR. STEFAAN BAFORT made a profit of €210,530.
Where can I find the annual accounts of DR. STEFAAN BAFORT?
DR. STEFAAN BAFORT filed 28 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. STEFAAN BAFORT due?
DR. STEFAAN BAFORT must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.